1-3 of 3
Michael W. Schmitt, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of the Sub-Clonal Origins of Compound Mutations in Patients with Refractory Ph+ Malignancies Treated with Ponatinib

Justin R. Pritchard, PhD, Michael W. Schmitt, MD PhD, J. Graeme Hodgson, PhD, Stephanie Lustgarten, PhD, Shijie Tang, PhD, Lawrence A. Loeb, MD PhD, Jerald P. Radich, MD, Victor M. Rivera, PhD
Journal: Blood
Blood (2016) 128 (22): 1061.
https://doi.org/10.1182/blood.V128.22.1061.1061
Published: 2016
Journal Articles

Toward Individualized Therapy: Correlation of Mutation Analysis with in Vitro high Throughput Drug Sensitivity Testing in New Diagnosis and Relapsed Acute Myeloid Leukemia

Pamela S. Becker, MD PhD, Michael W. Schmitt, MD PhD, Zhiyi Xie, PhD, Andrew R Carson, PhD, Bradley Patay, MD, Seyed Sina Khankhajeh, Qi Wei, Ling-Hong Hung, Timothy Martins, PhD, Elihu H. Estey, MD, C. Anthony Blau, MD, Vivian G. Oehler, MD, Ka Yee Yeung, PhD
Journal: Blood
Blood (2015) 126 (23): 3851.
https://doi.org/10.1182/blood.V126.23.3851.3851
Published: 2015
Journal Articles

Emergence of Sub-Clonal Drug Resistance Mutations during CML Therapy

Michael W. Schmitt, MD PhD, Justin R. Pritchard, PhD, Graeme Hodgson, PhD, Victor M. Rivera, PhD, Bella I. Aminov, Lan Beppu, Lawrence A. Loeb, MD PhD, Jerald P. Radich
Journal: Blood
Blood (2015) 126 (23): 478.
https://doi.org/10.1182/blood.V126.23.478.478
Published: 2015